Sintx Technologies (SINT) EBT Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -68,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68,801.00 |
| Dec 31, 2025 | -24,641.00 |
| Sep 30, 2025 | -106,201.00 |
| Jun 30, 2025 | -48,843.00 |
| Mar 31, 2025 | 158,429.00 |
| Dec 31, 2024 | 98,060.00 |
| Sep 30, 2024 | 19,948.00 |
| Jun 30, 2024 | 192,065.00 |
| Mar 31, 2024 | 247,796.00 |
| Dec 31, 2023 | 123,579.00 |
| Sep 30, 2023 | 322,344.00 |
| Jun 30, 2023 | 149,124.00 |
| Mar 31, 2023 | -61,909.00 |
| Dec 31, 2022 | -12,373.00 |
| Sep 30, 2022 | 19,640.00 |
| Jun 30, 2022 | -60,954.00 |
| Mar 31, 2022 | -52,604.00 |
| Jun 30, 2021 | -207,026.00 |
| Mar 31, 2021 | -245,477.00 |
| Dec 31, 2020 | -141,143.00 |
| Sep 30, 2020 | -364,363.00 |
| Jun 30, 2020 | -192,142.00 |
| Mar 31, 2020 | 58,421.00 |
| Dec 31, 2019 | -36,287.00 |
| Sep 30, 2019 | -68,229.00 |
| Jun 30, 2019 | -31,125.00 |
| Mar 31, 2019 | -159,819.00 |
| Jun 30, 2018 | 1,716.00 |
| Mar 31, 2018 | -3,871.00 |
| Dec 31, 2017 | 10,660.00 |
| Sep 30, 2017 | 3,192.00 |
| Jun 30, 2017 | 17,376.00 |
| Mar 31, 2017 | 6,206.00 |
| Dec 31, 2016 | -4,237.00 |
| Sep 30, 2016 | -10,923.00 |
| Jun 30, 2016 | -7,522.00 |
| Mar 31, 2016 | -1,391.00 |